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Background/aim: Guided bone regeneration (GBR) is commonly performed to repair bone defects, and rigid occlusive titanium barriers
play a vital role in bone formation in regions with no prior bone tissue. The statin, rosuvastatin (RSV), strongly affects bone apposition
when applied locally. Here, we aimed to evaluate the anabolic effects of locally applied RSV with a xenograft placed on rabbit calvaria.
Materials and methods: Two rigid occlusive titanium caps were used in 16 rabbits after decorticating the calvarial bone. In the control
group, the area under the cap was filled with a xenograft, while in the RSV group, a xenograft in combination with RSV (1 mg) was
used. In both groups, at 6 and 12 weeks, new bone, residual graft, soft tissue areas, and histological and radiological bone volume were
evaluated.
Results: At 12 weeks, histologically, the RSV group exhibited superior new bone proportion values, and radiologically, new bone and
total bone volume in the RSV group were significantly higher than in the control group (p < 0.05); there were no significant differences
at 6 weeks (p > 0.05).
Conclusion: According to our results, RSV applied locally under a titanium barrier on an area to be repaired with bone grafts increases
new bone and total bone volume.
Key words: Rosuvastatin, xenografting, bone transplantation, osteogenesis, HMG-CoA reductase inhibitors

1. Introduction
Guided bone regeneration (GBR) is commonly used to
repair bone defects associated with pathological lesions or
to increase bone volume before dental implant treatment
[1]. The barrier membranes that are used in GBR are
vitally important for appropriate bone formation. These
membranes prevent soft tissue from growing toward the
inside of the defect, and they protect the defect site until
bone tissue development is complete. The membranes
used in GBR need to have several characteristics in order to
ensure maximum bone regeneration. The most important
of these are biocompatibility, stiffness to maintain the
defect cavity, ability to prevent epithelial cell migration,
and permeability to ensure that the newly formed tissues
are fed [2]. However, another view suggests that a similar
amount of bone development can be achieved with the
use of impermeable titanium barriers as that achieved

on using permeable membranes [3]. The only drawback
of titanium barriers is that they require a second surgery
because they are not self-resorbable, despite which in many
studies, guided tissue regeneration using titanium barriers
has been successfully performed for bone regeneration in
rabbits [4,5].
Statins, which are 3-hydroxy-3-methylglutaryl
coenzyme-A (HMG-CoA) reductase inhibitors, were first
developed to treat patients suffering from hyperlipidemia
and hypercholesterolemia, and they were observed to
have positive effects in osteopathic patients as well [6].
Recently, statins were also shown to have a positive role
in bone formation as they modulate inflammation and
increase osteogenesis and angiogenesis [7,8]. Statins
increase the release of important osteoanabolic and
angiogenetic factors, such as bone morphogenetic protein
(BMP-2) and vascular endothelial growth factor (VEGF),
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[7]. Rosuvastatin (RSV) is a lipid-lowering agent that is
used to prevent cardiovascular disorders. In addition, it
has a longer half-life and produces stronger effects than
simvastatin and atorvastatin [9]. RSV is also known to
have pleiotropic effects, including bone stimulation,
increased vascularization, and antiinflammatory effects.
Following oral administration, statins are rapidly absorbed;
however, their systemic bioavailability is low owing to
their widespread first-pass metabolism in the liver [10].
Therefore, the oral administration of statins is known to
be ineffective in healing bone defects. Several studies have
revealed their positive effects on bone formation through
oral and subcutaneous administrations, and recent
research has been primarily aimed at uncovering the
optimal dosage and formulation of locally administered
RSV [11,12]. However, the effects of locally administered
RSV in GBR procedures in areas with no prior bone
formation still remain unclear.
Therefore, the aim of this study was to histologically
and radiologically evaluate the effects of RSV administered
locally together with a xenograft placed under a titanium
barrier at the bone augmentation site in a rabbit calvaria.
2. Materials and methods
2.1. Experimental model
This study protocol was performed in accordance with
National Institutes of Health (NIH) ARRIVE guidelines for
the care and use of laboratory animals and independently
reviewed and approved by the Animal Experiments Local
Ethics Committee of Hacettepe University on 29 May
2018 under the identification number, 2018/27-05. Sixteen
male New Zealand rabbits were used in this study. The
experimental animals were housed in cages at standardized
room temperature, humidity, ventilation, and fluorescent
light (imitating a light/dark cycle of 12 h each) settings for
a period of 1 week before the study was commenced in
order for them to adapt to the environmental and climatic
conditions. The study was designed such that each of
the experimental animals provided samples for both of
the study groups listed below (from the right side of the
calvaria for one group and from the left side of the calvaria
for the other).
•
RSV + xenograft group (RSV)
•
Xenograft/control group (C)
For the evaluation, each group was further divided
based on two healing period time frames, 6 weeks and
12 weeks. Care was taken to administer the RSV group
treatment on the left side of the calvaria and the C group
treatment on the right side of the calvaria in each animal.
2.2. Surgical procedure
All the animals were intramuscularly administered 35
mg/kg of ketamine hydrochloride (Alfamine, Alfasan,
Woerden, The Netherlands) and 2.5 mg/kg of xylazine
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hydrochloride (Alfazyne, Alfasan, Woerden, The
Netherlands) to induce anesthesia. The right and left cranial
regions were shaved, and the operation site was disinfected
using povidone-iodine (Batticon, Adeka, Samsun,
Turkey). To control bleeding, the site was infiltrated using
1 mL of a local anesthetic solution (Ultracain D-S forte,
Sanofi Aventis, Kırklareli, Turkey). Using a scalpel number
15, a ~4-cm long full-thickness incision was made on
the calvarium midline along the linea media in order to
include the periosteum, and the bone surface was exposed.
Seven decortication sites were opened up on the parietal
bones under sterile saline cooling using a round bur with
a diameter of 1.5 mm (Figure 1A). A preprepared 7-hole
titanium guide was used to standardize the decortication
sites. Subsequently, specially prepared titanium caps with
an outer diameter of 10 mm, a height of 5 mm, and a width
of 0.3 mm were glued onto the decorticated bone using
tissue adhesive (Leukosan Adhesive, Hamburg, Germany).
•
In the RSV group, a 0.5–1 mm particle size
0.15 cc xenograft (OsteoBiol-Apatos, Giaveno, Italy) was
soaked in a preprepared RSV solution (1 mg RSV-Sigma
Aldrich-/0.4 mL sterile saline) and was placed into an
opening with a diameter of 3 mm on the titanium cap.
•
In the C group, 0.15 cc xenograft (OsteoBiolApatos, Giaveno, Italy) with a particle size of 0.5–1 mm
was soaked in sterile saline was placed in the titanium cap
using the same method (Figure 1B).
Finally, the skin and subcutaneous tissue were
primarily sutured using a resorbable 16 mm 3/8 sharp
4.0 polyglactin suture (Coated Vicryl, Ethicon, Johnson
& Johnson, Machelen, Belgium). Wound closure spray
(Opsite, Smith & Nephew, Hull, UK) was applied onto the
sutured regions to prevent postoperative infection.
During the postoperative period, the subjects were
administered 1 mg/kg of meloxicam (Maxicam X4,
Sanovel, İstanbul, Turkey) to induce analgesia and 2.5
mg/kg of intramuscular enrofloxacin as antibiotic therapy
for 5 d (Baytril-K %5, Bayer, Kansas, US). The animals
were kept alive in separate cages during the experiment
under a light/dark cycle of 12 h each. The environmental
temperature was maintained at an average of 22–24 °C,
and the humidity, at 55%–70%. The health of the scar
regions was regularly examined, and adequate amounts of
food and water were supplied.
2.3. Tissue processing
The animals were sacrificed with a lethal dose of
intramuscular xylazine hydrochloride (30 mg/kg Alfazyne,
Alfasan, Woerden, The Netherlands) and ketamine
hydrochloride (70 mg/kg Alfamine, Alfasan, Woerden,
The Netherlands), half at the end of week 6 and the other
half at the end of week 12. The study area was excised from
each rabbit by an en bloc resection keeping some of the
bone tissue intact around it. After the titanium caps were
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Figure 1. Protocol for three-dimensional reconstruction in a rabbit model. A.
Decortication sites were opened up on the parietal bones. B. The area under the titanium
cap (10 × 5 × 0.3 mm) was filled with a xenograft on each side and the left one was
treated RSV.

separated from the bone, the specimens were divided into
subgroups in the case of each rabbit and were set in 10%
buffered formaldehyde for 48 h.
2.4. Radiological analysis
Radiologic analysis was performed by an examiner who
was blinded to the source of the samples. The specimens
were scanned in a microcomputed tomography (CT)
scanner (Skyscan 1174, Skyscan, Kontich, Belgium) with
a pixel size of 40 μm. The x-ray tube voltage was 50 kV,
and the current level was 800 μA. The exposure time was
2300 ms. X-ray projections were obtained at 0.70° intervals
with a scanning angular rotation of 180°. Subsequent
reconstructions of the raw data acquired during this
screening phase were obtained using the software program,
NRecon version 1.6.9.4 (NRecon, Skyscan, Kontich,
Belgium). Subsequently, 8-bit gray images reconstructed
using NRecon were transferred to the CTan software
program (version 1.13.5.1, Skyscan, Kontich, Belgium).
Basic values including bone volume, bone surface area,
soft tissue volume, soft tissue surface area, bone/soft
tissue ratio, bone density, etc. were obtained from selected
regions of interest (ROI).
2.5. Histologic analysis
Histological evaluations were performed in Hacettepe
University, Faculty of Medicine,
Department of Histology and Embryology. A
histologic analysis was performed by an examiner who
was blinded to the source of the samples. A total of 16

calvaria samples with two scaffolds on each were fixed
in 10% formaldehyde for 48–72 h, and they were then
decalcified in DeCastro solution (300 mL absolute ethanol,
50 g chloral hydrate, 670 mL distilled water, 30 mL 70%
nitric acid) for 20 ± 2 d. After embedding the samples into
paraffin blocks (Leica EC Embedding Center, Nussloch,
Germany), they were sectioned into two halves along
the midline of the scaffolds. Subsequently, 5 μm slices
of the sections along the midline of each sample were
prepared for the histological examination. The slices
were deparaffinized in a 65° oven for approximately 2 h
before the staining process. After processing them with
xylol and serial alcohol for 30 min, respectively, the slices
were stained with standard hematoxylin-eosin (HE) stain
for the histopathologic evaluation. The samples were also
stained with Masson’s trichrome stain to evaluate the
degree of new bone formation. For Masson’s trichrome
staining, the samples were treated with xylol and serial
alcohol for 30 min, washed with distilled water, and kept in
Bouin solution (picric acid 75 cc, 37%–40% formaldehyde
25 cc, glacial acetic acid 5 cc) in a 56° oven for 1 h. After
the samples were washed in a stream of distilled water,
they were stained with hematoxylin, washed again,
and passed through acid-alcohol and ammonia water,
respectively. Then, they were stained with trichrome dye
(chromotrope 2R 0.6 g, light green 0.3 g, glacial acetic acid
1 cc, phosphotungstic acid 0.8 g, distilled water 100 cc)
for 20 min, differentiated in acetic acid, and dehydrated
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by passing through serial alcohol. After staining, the
samples were examined under a Leica DMR microscope
(Leica Microsystems GmbH, Wetzlar, Germany) and were
photographed under magnifications of ×4, ×10, and ×40
using a Leica Application System (LAS Version 4.2.0, Leica
Microsystems GmbH, Wetzlar, Germany) connected to
a personal computer. The digital images were evaluated
for bone marrow formation, fibrous tissue formation,
bone trabeculae formation, and bone scaffold formation
during the bone healing process. In order to see the largest
diameter of the defect, the sections were all cut along
the midline. To objectively compare the morphological
differences, the authors used a semiquantitative scoring
system similar to the scale published by Santic et al., which
allows for a statistical analysis of the differences in the
bone healing processes between two groups of samples
[13]. The evaluation was carried out by two independent
observers. Bone marrow and fibrous tissue formation in
the scaffold were graded on a three-point scale (grade 1 =
located on lower 1/3 of the scaffold; grade 2 = reaches 2/3
of the scaffold; grade 3 = reaches the top of the scaffold)
and new bone trabeculae count was evaluated on a threepoint scale (grade 1, mild=≤5 new bone trabeculae;
grade 2, moderate=6-10 new bone trabeculae; grade 3,
intensive=≥11 new bone trabeculae). All the sections were
evaluated with a magnification of ×10 and stained with
H&E. While evaluating new bone formation, we measured
quantitatively new bone trabeculae proportion to the bone
graft particles in the scaffold areas. These calculations were
displayed with ×10 magnification lenses in the samples

stained with Masson trichrome dye. The newly formed
bone trabeculae and the old bone tissue together with
the graft in the defect area were selected separately by the
histogram method (Adobe Photoshop CS6, California,
USA) in different colors (new bone trabeculae in green,
old bone tissue in red) (Figure 2). The calculation was
performed in three different images of each sample at
the midline sections. Following this, these values were
summed up again and they were divided by the number
of samples to determine the average values of each group.
Quantitative morphometric analysis of undecalcified
new bone tissue was also calculated by micro CT which is
a newer method than decalcified histomorphometry. Also
we had compared the results of the two methods.
2.6. Statistical analysis
The data were analyzed using the SPSS 24.0 (SPSS Inc.,
Chicago, IL) statistical software package. Descriptive
statistics (mean, median, standard deviation) were used in
the analyses, and the Mann–Whitney U test was used to
compare variables between the different groups. In each
group, the data collected in the 6th week and 12th week
were compared by the Wilcoxon test. Type 1-error level
(alpha) values that were lower than 0.05 were considered
statistically significant. The frequencies of the categorical
data were presented as percentage values. Based on these
results, the suggested sample size for each technique was
calculated to run Wilcoxon–Mann–Whitney test two
groups with a desired power = 0.80 and α = 0.05. The
methodology was reviewed by an independent statistician.

Figure 2. Console used to calculate the new bone trabecule/bone graft proportion by histogram method in Masson
trichrome stained and ×10 magnified sample pictures.
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3. Results
In all the groups, histopathological evaluations were
performed at magnifications of ×4, ×10, and ×20. Scores
were assigned to evaluate bone healing via standard HE
staining, and the amount of bone trabeculae formed was
measured by Masson’s trichrome staining. Bone trabeculae
at various stages were observed in all the samples.
The number and thickness of new bone trabeculae that
were formed around the bone grafts in the RSV group were
lower during the early period and increased during the late
period. There were no differences in this group in terms
of the distribution and extent of bone marrow and fibrous
tissue formation. The C group was observed to exhibit less
bone formation during the early period (Figure 3A). There
were no changes in the newly formed bone trabeculae

between weeks 6-12. Further, there were no differences in
this group in terms of the distribution of bone marrow and
connective tissue.
When the samples prepared in the 6th week were
evaluated, it was observed that the bone height and density
values of the new bone trabeculae in the C group were
lower compared to those in the RSV group. No differences
were observed between the groups in terms of the extent
of connective tissue and bone marrow formation (Figure
3B). Examining the samples from the 12th week revealed
that the RSV group exhibited superior results in terms of
new bone trabeculae and total bone structure formation
with the proportion of new bone being 0.3351 (Table 1).
It was observed that almost all the bone grafts in the RSV
group were surrounded by new bone tissue. (Figure 3C).

Figure 3. Histological findings of the defect area, 6 weeks (A, B) and 12 weeks (C, D) after surgery. A. In the group C defect area consists
of anastomosing new bone trabeculae and loose collagen connective tissue (Masson trichrome, ×10). B. New bone trabeculae observed
at the RSV group. (Masson trichrome, ×10). C. Group C showing anastomosing new bone trabeculae (less than in the RSV group), graft
particles, and cellular structured collagen connective tissue (H&E, ×10). D. Specimens in the RSV group showing almost all bone graft
particles surrounded by new bone trabeculae. (H&E, ×10). (H&E, hematoxylin and eosin; scale bar, 200 µm; group C, xenogeny bone
grafting; RSV group, rosuvastatin with xenogeny bone grafting; BT, arrow, new bone trabeculae; BG, graft material; BM, bone marrow;
CT, connective tissue).
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Table 1. The new bone trabeculae/bone graft proportion of the
samples.

6 weeks
12 weeks

Groups

New bone proportion

RSV (n = 4)

0.1320 ± 0.0579

C (n = 4)

0.0937 ± 0.0227

RSV (n = 4)

0.3351 ± 0.0156

C (n = 4)

0.1975 ± 0.0493

No differences were observed between the groups in the
connective tissue stage. Bone marrow development was
also noted to be more prominent in the RSV group (Figure
3D, Table 2).
The radiological examination revealed that the total
bone volume in the RSV group was significantly higher
compared to in the C group at the 12-week timepoint
(p < 0.05). In both the groups, the values in week 6 were
significantly different compared to the values in week 12 (p
< 0.05). The new bone volume was not significantly different
between the groups in week 6 (p > 0.05), but in week 12,
the values of the RSV group were significantly higher
compared to those of the C group (p < 0.05). Additionally,
at the 12-week timepoint, the values were significantly
higher compared to those at the 6-week timepoint in both
groups (p < 0.05). The residual graft volume values of the
RSV group were significantly different compared to those
of the C group at the 12-week timepoint (p < 0.05). There
were no significant differences in values at the 6-week
timepoint (p > 0.05). The bone density was not significantly
different between the groups in both the weeks (p > 0.05).
The total porosity (percent) and trabecular thickness values
were not significantly different between the groups at both
the timepoints (p > 0.05); however, the values at the 6-week
timepoint were significantly different compared to those at
the 12-week timepoint (p < 0.05), (Figures 4 and 5).
4. Discussion
The basis of the GBR approach is to prevent the invasion of
fast-growing tissues into the bone regeneration site and to

optimize bone healing. In addition, this approach protects
the regeneration site and ensures that the relevant growth
factors remain within the region. It is a method that has
been used for a long time by many surgeons in the following
procedures: vertical and horizontal augmentation of
the alveolar bone, maxillary sinus lifting operations,
and peripheral nerve surgeries. Today, jaw bones can be
successfully reconstructed by maxillofacial surgeons using
various GBR methods and materials [14,15].
The use of bone graft materials is very important in
the three-dimensional reconstruction of bone defects.
Autogenous grafts stimulate new bone formation owing
to their osteogenic properties. Thus, they are the gold
standard and are the primary choice when selecting
bone graft material. However, since they require a second
operation site, they increase surgery time, morbidity
rates, postoperative discomfort, recovery time, and costs.
Moreover, the rate of resorption of autologous grafts is
still a serious disadvantage. Therefore, in clinical practice,
it has become more common to use other graft materials,
one of which is bovine bone grafts. Xenografts, such as
bovine grafts, save the patient from autologous bone
retention, provide a stable scaffold for bone formation,
and maintain long-term graft volume stability owing to
their low resorption rates [16]. These are the reasons why
bovine bone grafts were preferred in this study. Xenografts
could be found in different physical forms such as putty,
granule or block. The physical characteristics of the grafts
that affect bone healing through their osteoconduction
properties are the pore size, the grain size, surface
morphology and crystallinity of the material. Pores larger
than 50 μm favor osteogenesis because of vascularization
with cell recruitment and interconnecting pores of graft
are beneficial for bone formation. In this study, a granuleshaped xenograft with a particle size of 0.5–1 mm, known
to be the closest to the natural bone structure, was used.
However, the results obtained in this study should be
compared with the studies to be done with xenografts with
different physical chemical structures [17].
Recently, it has been considered that the membrane
used for GBR is more than just a passive barrier and that

Table 2. The frequency of histomorphological parameters as a percentage.
Bone marrow grade
(%)

New bone on the surface
grade (%)

New bone trabeculae
grade (%)

Fibrous tissue formation
grade (%)

1

2

3

1

2

3

1

2

3

1

2

3

RSV

-

75

25

-

25

75

25

75

-

100

-

-

C

25

75

-

25

62.5

12.5

75

25

-

75

12.5

12.5

RSV

12.5

37.5

50

-

12.5

87.5

12.5

75

12.5

100

-

-

C

-

87.5

12.5

-

50

50

75

25

-

75

25

-

Groups

6 weeks
12 weeks
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180.000
*

160.000

*
a

a

140.000

*
*

120.000
100.000
80.000

*

60.000
*

40.000

0.000

a

a

20.000

C

RSV

Residual Graft Volume (mm3)

C

a

RSV

C

New Bone Volume (mm3)

6. weeks

RSV

Total Bone Volume (mm3)

a

C

RSV

Total porosity (%)

12. weeks

Figure 4. Comparison of values for the total bone volume, new bone volume, residual graft volume and total porosity derived from
radiographs obtained 6 and 12 weeks after surgery. Data are presented as the mean ± standard deviation (Group C, xenogeny bone
grafting only; group RSV, rosuvastatin with xenogeny bone grafting; a, significantly different from values obtained 12 weeks after
surgery; *, significantly different from values obtained in the other group, black line indicates the standard deviation).

Figure 5. Microcomputed tomography (CT) images of all groups at 6 weeks and 12 weeks.
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it plays an active role in promoting bone regeneration.
Irrespective of the type of graft material used, ensuring
stabilization through the duration of the healing period of
the graft material is an important criterion for success. In
addition, any mechanical stress applied onto the healing
bone graft will cause the initial fibrin clot to deteriorate,
leading to fibrous tissue being formed during the healing
process. It is important to choose the most suitable type
of surgical procedure from those involving the use of
materials, such as collagen-containing membranes,
titanium meshes, titanium caps, or bone screws.
Collagen structured membranes are known to function
as a mechanical barrier during the critical period that is
specified as 3–4 weeks in the literature to allow for selective
cell passage and to prevent inflammatory response during
resorption [18]. However, these techniques cannot ensure
sufficient stabilization of the graft material, especially in
defects with fewer walls. To overcome this, we preferred
to use rigid hemispheric titanium barriers in this study. It
has previously been suggested that occlusive membranes
can prevent certain types of growth factors from entering
the site and, therefore, prevent bone formation [19,20].
However, subsequent studies have revealed that it is not
required for undifferentiated mesenchymal cells to invade
the site from surrounding soft tissues to ensure successful
ossification in the region [21,22]. In this study, we observed
that the use of a barrier without a pore structure did not
affect bone formation. The most important advantages
of hemispheric titanium barriers are their biocompatible
structure and the ability to ensure proper stability owing
to their adequate stiffness, especially in cases in which
a particulate graft material is preferred; however, their
disadvantages, such as mucosal perforations and the need
for a second surgery, should also be considered.
The anabolic effects of statins on bone tissue were first
described by Mundy et al., and studies on their effects on
catabolic bone diseases, such as osteoporosis, have since
been conducted [6]. In vitro studies have shown that statins
affect osteoblast and osteoclast functions via the mevalonate
pathway and that they have strong anabolic effects on
vascular endothelial cells and endothelial progenitor cells.
While in vivo animal studies have demonstrated that
statins administered systemically can reduce bone loss due
to inflammation, some clinical studies have reported that
they can reduce the risk of osteoporotic bone fracture and
increase bone mineral density [23]. Previous studies have
also demonstrated that statins exhibit low bioavailability
when they are orally administered, since they are rapidly
absorbed and metabolized in the liver [24]. Thus, as
the administration of statins gained popularity, local
application methods started to be investigated, and it was
shown that statins applied topically were 50 times more
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active than those applied orally [25]. There have since
been many animal studies that involved RSV being applied
locally in fracture healing, implant applications, long bone
defect models, and craniofacial defect models. There are
also several clinical trials in which RSV was applied locally,
especially in patients with periodontal diseases. In light of
this information, it was considered that local application
was more effective in optimizing the osteoinductive effect;
therefore, local application was preferred in this study.
It is noteworthy to mention that there are a variety of
methods outlined in the literature via which statins can be
applied locally. Wu et al. used polylactic acid/polyglycolic
acid copolymers as carriers, and Ibrahim et al. transferred
statins to the relevant site using a biodegradable sponge
[26,27]. Mukozawa et al. used a hydrogel and absorbable
collagen sponge as the carrier material and achieved
similar positive results with both [28]. Liu et al. used a
hydrogel as the carrier for the intraosseous application of
statins and highlighted the positive features of hydrogels,
such as biocompatibility, low toxicity, and adequate
stability [29]. Monjo et al. mentioned that the sustained
release of a compound with low molecular weight, such as
statins, would not be possible with the use of any carrier
system [10]. However, there is no clear information in the
literature on which carrier system is more advantageous.
In this study, the bone graft material was also used as the
carrier material. Therefore, no other material was required
to act as a carrier. The results of this study also support
that an additional carrier material is not required for statin
application and that the graft material can also serve as
a good carrier. We considered that one reason for this is
that the barrier we used is of the rigid occlusive type. In
future studies, a suitable carrier system to improve the
slow release of statins, to facilitate bone formation, and
to prevent the initial inflammatory response should be
investigated.
RSV, a HMG-CoA reductase inhibitor, produces the
strongest effect among the currently used statins and
is effective in lowering low-density lipoprotein (LDL)
cholesterol levels [30]. According to Karlson et al., RSV
is eight times stronger than simvastatin [9]. In addition,
Pradeep et al. demonstrated that RSV was a more effective
type of statin in their study in which they compared the
effects of RSV with those of atorvastatin [31]. RSV was
chosen as the statin type in this study, and positive effects
on bone graft healing were demonstrated.
During our literature review, we did not find a definite
consensus on the appropriate dose of locally administered
RSV. Pradeep et al. used 1.2 mg of RSV for intrabone
defects and furcation defects in their study [31,32]. Monjo
et al. used three different doses, 0.1, 0.5 and 2.5 mg, and
outlined the toxic effects that may occur in the case of
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higher doses [10]. Türer et al. used two different doses,
0.1 and 1 mg, in their calvarial bone defect study on rats
and determined that the optimal dose was 1 mg [33]. In
their subsequent study, they used a fractured rat mandible
model and a 1 mg dose of RSV and demonstrated a positive
effect on healing [34]. In the current study, a 1 mg dose of
RSV was used, and it was demonstrated to have positive
effects on both new bone and total bone volume.
The reason why rabbits were chosen as the experimental
animals in this study was to ensure that both the study
sample groups were from the same animal in order to
prevent individual differences. We decided to use the
calvaria as our study site for the following reasons: it is
not difficult to work on this site; complications, such as,
postoperative exposures were less likely to occur in this
region; and we considered the study models used in the
literature [21,22]. According to Ito et al., titanium caps
have been evaluated to be an important material that
results in bone formation in regions without bones [35].
In the study by Marechal et al., occlusive titanium barriers
that were used for bone augmentation were reported to be
more advantageous than other techniques with respect to
new bone formation [36]. Unlike in the case of a defect
model, titanium caps that have been used by many
researchers to induce bone formation in regions with no
bone tissue were observed to yield successful results in
this study. The key points in achieving these successful
results are ensuring the stabilization of the barrier material
and impermeability between the bone and barrier. In this
study, the stabilization and impermeability of the titanium
caps were facilitated by N-butyl-2-cyanoacrylate that is
often used as a tissue adhesive. Moreover, known to play
an important role in bone augmentations, decortication
has been demonstrated to be indispensable in ensuring
blood supply and increasing bone morphogenetic protein
and other growth factor levels in previous studies [36–
38]. Furthermore, Min et al., in their study on rabbits,
demonstrated that decortication was crucial; however, the
size of the decortication site was insignificant in terms of
augmentation. Therefore, in this study, decortication was
performed in the regeneration area under the titanium
cap, and it was ensured that the site was equal in size in all
the groups to ensure standardization.
In previous studies on rabbits, a 4-week period was
found to be sufficient to ensure angiogenesis and new
bone formation in the defect region [39]. However, unlike
in the case of the defect model, this study dealt with bone
formation in an area with no prior bone. On researching
studies that involved similar models and histological and
radiological changes, we found that a 12-week period was
required to determine the bone regeneration capacity
of RSV [24,25]. In this study, the study timepoints were

determined to be 6 and 12 weeks to examine the early and
late effects of RSV on bone augmentation.
The most reliable methods to measure newly formed
bone and soft tissue amounts are two-dimensional
histomorphometric analyses and three-dimensional
micro-CT analyses. However, in histomorphometric
examinations, larger sections of samples are required
compared to in a micro-CT analysis. Therefore, this
technique has been reported to generate more accurate and
detailed results compared to in studies that used microCT analyses [40]. However, the samples used in micro-CT
analyses do not get degraded, which is very important as
it allows for histological examinations and comparisons.
In this case, the histological results were supported by the
radiological results.
The effects of RSV have previously been investigated
in various models, such as in defect and fracture models;
however, it was used in a three-dimensional reconstruction
model for the first time in this study, and its positive effects
on bone healing were demonstrated. We consider that such
methods that can result in bone formation in regions with
no prior bone tissue unlike in defect model studies, would
be highly effective in procedures, such as vertical and
horizontal alveolar bone reconstructions, which involve
challenges and requirements, such as implant surgery,
before they are performed.
Bone regeneration is a complex, well-orchestrated
physiological process of bone formation, which can be seen
during normal bone healing, and is involved in continuous
remodeling throughout adult life. In this study, it has been
shown that RSV demonstrates its efficacy on new bone
formation and total bone volume. This study includes a 12week recovery period, and the effectiveness of RSV in this
process has been comparatively demonstrated over two
different time periods. Therefore, instead of using the term
bone healing, we used the term bone formation in our
hypothesis. In addition, for bone healing, resorption of all
graft material and new bone formation must be completed.
In this study, using the term bone healing was avoided.
The total bone volume data included both new bone and
residual graft amount. When analyzing the results of this
study, new bone formation data will be more valuable than
the total bone volume data. Thus new bone formation that
defines bone formation can be carefully studied.
Finally, based on the results of this study, the statin,
RSV, when administered locally produces strong effects
that stimulate bone formation. However, further studies
are needed with different doses and graft materials using
different animal models.
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